These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 11395684)

  • 1. [Encephalopathy induced by ingestion of ammonium during valproate therapy].
    Dumont O; Plauchu G; Scoazec JY; Cuber JC; Guegen L; Paliard P; Dumortier J
    Gastroenterol Clin Biol; 2001 Mar; 25(3):325-7. PubMed ID: 11395684
    [No Abstract]   [Full Text] [Related]  

  • 2. [Valproate-associated hyperammonemic encephalopathy. Report of one case].
    Young P; Finn BC; Alvarez F; Bruetman JE; Trimarchi H
    Rev Med Chil; 2007 Nov; 135(11):1446-9. PubMed ID: 18259656
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Valproate-induced hyperammonemic encephalopathy. Review of cases in the psychiatric setting].
    Fassi G; Igoa A; Liste OA
    Vertex; 2008; 19(82):371-7. PubMed ID: 19424520
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Encephalopathy associated with hyperammonemia in an alcoholic patient treated with sodium valproate].
    Mattei A; Bernard G; Plauchu G; Paliard P
    Gastroenterol Clin Biol; 1993; 17(6-7):516-7. PubMed ID: 8243949
    [No Abstract]   [Full Text] [Related]  

  • 5. A case of valproate-induced hyperammonaemic encephalopathy.
    Lucie O; Nazir F; Spilg E
    Scott Med J; 2013 Feb; 58(1):e43-4. PubMed ID: 23596040
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Valproate-induced hyperammonemic encephalopathy treated by hemodialysis.
    Tsai MF; Chen CY
    Ren Fail; 2008; 30(8):822-4. PubMed ID: 18791959
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hyperammonemia and valproic acid-induced encephalopathy.
    Modjtahedi B; Xiong GL
    Am J Psychiatry; 2007 Dec; 164(12):1912-3; author reply 1913-4. PubMed ID: 18056251
    [No Abstract]   [Full Text] [Related]  

  • 8. Valproate-induced hyperammonemic encephalopathy in a renal transplanted patient.
    Melexopoulou C; Marinaki S; Darema M; Skalioti C; Efthimiou A; Zavos G; Boletis JN
    Ren Fail; 2014 Jul; 36(6):955-6. PubMed ID: 24665854
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Report of three cases of hyperammonaemic encephalopathy associated with valproic acid due to possible synergism with phenobarbital and topiramate].
    Cano-Zuleta A; Hernández-Ortíz OH; González-González CA; Amariles P
    Farm Hosp; 2012; 36(5):441-2. PubMed ID: 22266198
    [No Abstract]   [Full Text] [Related]  

  • 10. Valproate-induced encephalopathy.
    Rehman A; Zafar S
    J Coll Physicians Surg Pak; 2005 Sep; 15(9):571-2. PubMed ID: 16181582
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Severe hyperammonaemic encephalopathy resulting from the overlap between hepatic and valproate encephalopathy.
    Izadi Firouzabadi L; Geer K; Mead P;
    Postgrad Med J; 2018 Nov; 94(1117):664. PubMed ID: 30397004
    [No Abstract]   [Full Text] [Related]  

  • 12. Valproate-induced hyperammonemic encephalopathy and normal liver functions: possible synergism with topiramate.
    Deutsch SI; Burket JA; Rosse RB
    Clin Neuropharmacol; 2009; 32(6):350-2. PubMed ID: 19952878
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Valproate-induced reversible pseudoatrophy of the brain and hyperammonemic encephalopathy in a bipolar patient.
    Abreu LN; Issler C; Lafer B
    Aust N Z J Psychiatry; 2009 May; 43(5):484-5. PubMed ID: 19382315
    [No Abstract]   [Full Text] [Related]  

  • 14. Hippocampal involvement in valproate-induced acute hyperammonemic encephalopathy.
    Soares-Fernandes JP; Machado A; Ribeiro M; Ferreira C; Figueiredo J; Rocha JF
    Arch Neurol; 2006 Aug; 63(8):1202-3. PubMed ID: 16908754
    [No Abstract]   [Full Text] [Related]  

  • 15. [A case report of valproate encephalopathy].
    Miyamoto T; Miyamoto M; Hirata K; Katayama S
    Rinsho Shinkeigaku; 1999 Oct; 39(10):1075-7. PubMed ID: 10655774
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Valproate-induced hyperammonemic encephalopathy.
    Bhatia H; Raman PG
    J Assoc Physicians India; 2005 Feb; 53():158. PubMed ID: 15847043
    [No Abstract]   [Full Text] [Related]  

  • 17. [Metabolic encephalopathy can be a potentially life-threatening complication from valproic acid].
    Meinardi MC; van den Berg GB; Groenhuijzen A; Driessen JT; Maas HA; Wolfhagen FH
    Ned Tijdschr Geneeskd; 2008 Feb; 152(5):278-82. PubMed ID: 18333544
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Hyperammonemic encephalopathy associated with valproate acid].
    Osuna MT; Burcet J; Ramió L; Ustrell X; Silva Y; Molins A
    Neurologia; 2003; 18(6):347-50. PubMed ID: 12838456
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Valproate-induced hyperammonemic encephalopathy associated with urinary tract infection and urinary retention in the psychiatric setting.
    Dawson LP; Lee SJ; Hollander YS
    Aust N Z J Psychiatry; 2016 Nov; 50(11):1110. PubMed ID: 27056174
    [No Abstract]   [Full Text] [Related]  

  • 20. Valproic acid induced encephalopathy--19 new cases in Germany from 1994 to 2003--a side effect associated to VPA-therapy not only in young children.
    Gerstner T; Buesing D; Longin E; Bendl C; Wenzel D; Scheid B; Goetze G; Macke A; Lippert G; Klostermann W; Mayer G; Augspach-Hofmann R; Fitzek S; Haensch CA; Reuland M; Koenig SA
    Seizure; 2006 Sep; 15(6):443-8. PubMed ID: 16787750
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.